Theodoros Roumeliotis

26PUBLICATIONS
185CO-AUTHORS
Haematological tumoursMolecular targetsMolecular, biological, and multi-scale communicationsBiomedical instrumentationCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Aug 12, 2026
RNA terminal uridylyl transferases are druggable vulnerabilities in AML but are dispensable for normal hematopoiesis.

|Apr 25, 2026
Cryo-EM structures of the CDK11-cyclin L-SAP30BP complex reveal mechanisms of CDK11 regulation.

|Feb 18, 2026
LOX Inhibition Disrupts a Collagen-Integrin-MYC Axis to Suppress Progression of Invasive Lobular Carcinoma.

Renée L Flaherty, Flavia Hughes, George Sflomos

|Feb 02, 2026
UltraPlex-TMT: Expanding Isobaric Hyperplexing via Orthogonal Protease Cleavage.

Theodoros I Roumeliotis, Fernando J Sialana, Jenny Ho

|Jan 12, 2026
Unhooking the Hook: Optimization of the Aurora A Targeting PROTAC JB170 to CCT400028, an In Vitro Degrader Chemical Probe.

Jack A O'Hanlon, Katrin Gutsche, Juliane Elisabeth Müller

|Oct 16, 2025
Structural basis of T-loop-independent recognition and activation of CDKs by the CDK-activating kinase.

Victoria I Cushing, Amy J S McGeoch, Sophie L Williams

Pageof 5

Frequent Collaborators

21 joint publications

Jyoti Sharma Choudhary

4 joint publications

Syed Haider

4 joint publications

Christopher J Lord

3 joint publications

Udai Banerji